Targeted enzyme prodrug therapy for metastatic prostate cancer – a comparative study of L-methioninase, purine nucleoside phosphorylase, and cytosine deaminase

BACKGROUND: Enzyme prodrug therapy shows promise for the treatment of solid tumors, but current approaches lack effective/safe delivery strategies. To address this, we previously developed three enzyme-containing fusion proteins targeted via annexin V to phosphatidylserine exposed on the tumor vascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Guillen, Katrin P, Kurkjian, Carla, Harrison, Roger G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223417/
https://www.ncbi.nlm.nih.gov/pubmed/25047949
http://dx.doi.org/10.1186/s12929-014-0065-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223417/
https://www.ncbi.nlm.nih.gov/pubmed/25047949
http://dx.doi.org/10.1186/s12929-014-0065-3

Ejemplares similares